INIS
women
100%
cancer
74%
kazakhstan
54%
risks
53%
humans
48%
patients
46%
pregnancy
41%
losses
37%
management
29%
fertility
26%
reviews
25%
ovaries
21%
genes
19%
screening
18%
genotype
18%
surgery
18%
data
18%
populations
16%
epidemiology
15%
control
13%
sampling
13%
mortality
13%
cytology
13%
levels
13%
applications
12%
comparative evaluations
11%
females
11%
diseases
11%
biopsy
11%
interventions
10%
fertilization
10%
death
10%
surveys
10%
distribution
10%
strains
9%
hospitals
9%
etiology
9%
pain
9%
proteins
9%
vaccines
9%
in vitro
8%
preservation
8%
quality of life
8%
obstetrics
8%
inflammation
8%
implementation
7%
audits
7%
workers
6%
environment
6%
cysts
6%
Medicine and Dentistry
Prevalence
28%
Cervical Cancer
25%
Papillomavirus Infection
17%
Recurrent Pregnancy Loss
16%
Wart Virus
15%
Cross Sectional Study
15%
Cervical Cancer Screening
11%
Cohort Effect
11%
Endometrial Biopsy
10%
Malignant Neoplasm
10%
Infection
10%
Endometriosis
9%
Uterus Bleeding
9%
Awareness
9%
Biopsy
9%
Diagnosis
8%
Human Papillomavirus Type 16
7%
Obstetrics
7%
Cytotechnology
7%
Papanicolaou Stain
7%
Genotype
6%
Quality of Life
6%
Endometrial Cancer
6%
Cohort Analysis
6%
Adnexal Mass
6%
In Vitro Fertilisation
6%
Predictive Marker
6%
Disease
6%
Cervical Cancer Prevention
5%
Human Papillomavirus Type 18
5%
Fertility Preservation
5%
Ovarian Cyst
5%
Screening
5%
Outpatient
5%
Keyphrases
Recurrent Pregnancy Loss
16%
Kazakhstan
15%
Cervical Cancer
13%
Etiology
8%
Risk Factors
7%
High-risk Human Papillomavirus (HR-HPV)
7%
Endometriosis
6%
Endometrial Cancer
6%
Risk Diagnosis
6%
Risk Management
6%
Adnexal Mass
6%
Gene Polymorphism
6%
Factor Diagnosis
6%